Listen on the go
CORRECT!
Next question
touchNEUROLOGY touchNEUROLOGY

Start Learning

Touch Loading image
touchFEATURE
Start Learning
The use of biomarkers for the accurate and timely diagnosis of Alzheimer’s disease in clinical practice
Sponsored content
touchMEETING HIGHLIGHTS
Start Learning
Genetic counseling and testing: advancements, barriers, and opportunities in rare disease
Sponsored content
JOURNALS
Start Learning
Driving awareness and action with Parkinson’s Europe in 2025
touchEXPERT OPINIONS
Start Learning
The path from detection to personalized long-term care for Fabry disease
CE/CME ACCREDITED
touchIN CONVERSATION
Start Learning
Early diagnosis and treatment of NMOSD: Practical insights
CE/CME ACCREDITED
JOURNALS
Start Learning
Supporting Brain Awareness Week 2025: Advancing knowledge in brain science
touchMEETING HIGHLIGHTS
Start Learning
Genetic counseling and testing in neuromuscular disease
Sponsored content
touchEXPERT FOCUS
Start Learning
Management of neurofibromatosis: Optimizing treatment and care from childhood to adult life
CE/CME ACCREDITED
JOURNALS
Start Learning
European experts release updated consensus on gene therapy for spinal muscular atrophy: Key recommendations for treatment
touchMEETING HIGHLIGHTS
Start Learning
Past Successes & Future Innovations in MS: Taking on Disability Accumulation Through Personalised Care, Biomarkers, and Clinical Trial Design
Sponsored content

to view Favourites, Keep Notes and Track CME Credits

Favourites
Foreword: touchREVIEWS in Neurology, Volume 20, Issue 1, 2024
View
New study reveals Alzheimer’s disease progresses in two distinct phases
View
Mentorship, discovery and future vision: A Q&A with Dr Stewart Tepper
View
Driving awareness and action with Parkinson’s Europe in 2025
View
Genetic counseling and testing: advancements, barriers, and opportunities in rare disease
View
New guidelines for epilepsy and pregnancy: AAN, AES and SMFM collaboration
View
Early diagnosis and treatment of NMOSD: Practical insights
View
Tenecteplase receives FDA approval for acute ischemic stroke
View
Research Highlights from EAN 2024
View
Motor gains achieved by 83% of paediatric SMA patients treated with onasemnogene abeparvovec
View
Copied to clipboard!
accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72
Close Popup